Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombotic Thrombocytopenic Purpura Registry - A Prospective Observational Study for Patients Suffering From Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

NCT01257269 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT01257269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombotic Thrombocytopenic Purpura Registry - A Prospective Observational Study for Patients Suffering From Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2006
Completion date
October 31, 2030
Enrollment
450 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

congenital thrombotic thrombocytopenic purpura, familial thrombotic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, congenital, upshaw-schulman syndrome